Fluvoxamine
"Fluvoxamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.
| Descriptor ID |
D016666
|
| MeSH Number(s) |
D02.092.570.665.250
|
| Concept/Terms |
Fluvoxadura- Fluvoxadura
- Merck dura Brand of Fluvoxamine Maleate
Fluvoxamin-ratiopharm- Fluvoxamin-ratiopharm
- Fluvoxamin ratiopharm
- Ratiopharm Brand of Fluvoxamine Maleate
- ratio-Fluvoxamine
- ratio Fluvoxamine
Luvox- Luvox
- Solvay Brand of Fluvoxamine Maleate
- Fevarin
- Floxyfral
- Dumirox
- Faverin
Novo-Fluvoxamine- Novo-Fluvoxamine
- Novo Fluvoxamine
- Novopharm Brand of Fluvoxamine Maleate
Nu-Fluvoxamine- Nu-Fluvoxamine
- Nu Fluvoxamine
- Nu-Pharm Brand of Fluvoxamine Maleate
- Nu Pharm Brand of Fluvoxamine Maleate
PMS-Fluvoxamine- PMS-Fluvoxamine
- PMS Fluvoxamine
- Pharmascience Brand of Fluvoxamine Maleate
Desiflu- Desiflu
- Declimed Brand of Fluvoxamine Maleate
|
Below are MeSH descriptors whose meaning is more general than "Fluvoxamine".
Below are MeSH descriptors whose meaning is more specific than "Fluvoxamine".
This graph shows the total number of publications written about "Fluvoxamine" by people in this website by year, and whether "Fluvoxamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluvoxamine" by people in Profiles.
-
Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999 May; 156(5):756-60.
-
Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry. 1997 Jul; 58(7):291-7.